arrow
K

Khandan Keyomarsi

university of texas md anderson cancer center
H指数:59
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CDK2 inhibitor BLU-222 synergizes with CDK4/6 inhibitors in drug resistant breast cancers through p21/p27 induction

CDK2抑制剂BLU-222通过p21/p27诱导与CDK4/6抑制剂在耐药性乳腺癌中的协同作用

2026-01-220
OAAI
CDK2 inhibition enhances CDK4/6 inhibitor antitumor activity in comprehensive breast cancer PDX model screen

CDK2抑制增强了CDK4/6抑制剂在综合乳腺癌PDX模型筛选中的抗肿瘤活性

2025-12-030
OAAI
IL-6 predicts CDK4/6 inhibitor resistance, identifying STAT3 as a target in HR + /HER2-negative metastatic breast cancer

IL-6预测CDK4/6抑制剂耐药性,确定STAT3为HR + /HER2阴性转移性乳腺癌的靶点

2025-07-250
OAAI
Single-cell RNA sequencing identifies molecular biomarkers predicting late progression to CDK4/6 inhibition in patients with HR+/HER2-metastatic breast cancer

单细胞RNA测序识别预测HR+/HER2-转移性乳腺癌患者对CDK4/6抑制剂的晚期进展的分子生物标志物

2025-02-151
OA
STAT3 protects hematopoietic stem cells by preventing activation of a deleterious autocrine type-I interferon response
LEUKEMIA
IF13.4
2024-03-111
OA